Cargando…

Nearly Pain-Free Self-administration of Subcutaneous Methotrexate With an Autoinjector: Results of a Phase 2 Clinical Trial in Patients With Rheumatoid Arthritis Who Have Functional Limitations

BACKGROUND: A methotrexate autoinjector (MTXAI) was developed for self-administration of subcutaneous (SC) methotrexate by patients with rheumatoid arthritis (RA). The MTXAI circumvents the need for vials, needles, and syringes and may therefore improve dosing accuracy, handling risks, and patient a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Freundlich, Bruce, Kivitz, Alan, Jaffe, Jonathan S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2014
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4165470/ https://www.ncbi.nlm.nih.gov/pubmed/25036562 http://dx.doi.org/10.1097/RHU.0000000000000117

Ejemplares similares

Head-to-head, randomised, crossover study of oral versus subcutaneous methotrexate in patients with rheumatoid arthritis: drug-exposure limitations of oral methotrexate at doses ≥15 mg may be overcome with subcutaneous administration
por: Schiff, Michael H, et al.
Publicado: (2014)

Evaluation of Usability and Acceptance of a New Autoinjector Intended for Methotrexate Subcutaneous Self-Administration in the Management of Rheumatoid Arthritis
por: Hudry, Christophe, et al.
Publicado: (2017)

Potential Benefits of the Self-Administration of Subcutaneous Methotrexate with Autoinjector Devices for Patients: A Review
por: Tornero Molina, Jesús, et al.
Publicado: (2021)

Assessing usability, label comprehension, pen robustness and pharmacokinetics of a self-administered prefilled autoinjector pen of methotrexate in patients with rheumatoid arthritis
por: Pachon, Jaime A, et al.
Publicado: (2014)

Usability and Acceptability of the Abatacept Pre-Filled Autoinjector for the Subcutaneous Treatment of Rheumatoid Arthritis
por: Schiff, Michael, et al.
Publicado: (2016)

Methotrexate and Rheumatoid Arthritis: Current Evidence Regarding Subcutaneous Versus Oral Routes of Administration
por: Bianchi, Gerolamo, et al.
Publicado: (2016)

Methotrexate: who would have predicted its importance in rheumatoid arthritis?
por: Weinblatt, Michael E.
Publicado: (2018)

Patient’s experience with subcutaneous and oral methotrexate for the treatment of rheumatoid arthritis
por: Curtis, J. R., et al.
Publicado: (2016)

Patients’ Perceptions and Preferences Regarding Two Different Forms of Methotrexate Autoinjectors for Moderate to Severe Rheumatoid Arthritis: A European Crossover Survey
por: Zeitoun, Jean-David, et al.
Publicado: (2020)

Evaluation of a novel autoinjector for subcutaneous self-administration of belimumab in systemic lupus erythematosus
por: Sheikh, Saira Z., et al.
Publicado: (2016)

Patients’ and nurses’ preferences for autoinjectors for rheumatoid arthritis: results of a European survey
por: Tischer, Bernd, et al.
Publicado: (2018)

Patient Evaluation of Satisfaction and Outcomes with an Autoinjector for Self-Administration of Subcutaneous Belimumab in Patients with Systemic Lupus Erythematosus
por: Dashiell-Aje, Ebony, et al.
Publicado: (2017)

Pharmacokinetics of Subcutaneous Dupilumab Injection With an Autoinjector Device or Prefilled Syringe
por: Cohen, Yehuda Z., et al.
Publicado: (2022)

Who Needs Epinephrine? Anaphylaxis, Autoinjectors, and Parachutes
por: Dribin, Timothy E., et al.
Publicado: (2023)

Pharmacokinetics and Pharmacodynamics of Subcutaneous Sarilumab and Intravenous Tocilizumab Following Single‐Dose Administration in Patients With Active Rheumatoid Arthritis on Stable Methotrexate
por: Paccaly, Anne J., et al.
Publicado: (2020)

Utilization of Subcutaneous Methotrexate in Rheumatoid Arthritis Patients After Failure or Intolerance to Oral Methotrexate: A Multicenter Cohort Study
por: Branco, Jaime C., et al.
Publicado: (2016)

Safety and efficacy of baricitinib at 24 weeks in patients with rheumatoid arthritis who have had an inadequate response to methotrexate
por: Keystone, Edward C, et al.
Publicado: (2015)

Methotrexate-loaded multifunctional nanoparticles with near-infrared irradiation for the treatment of rheumatoid arthritis
por: Ha, You-Jung, et al.
Publicado: (2020)

Pharmacokinetic Profile of Subcutaneous Testosterone Enanthate Delivered via a Novel, Prefilled Single‐Use Autoinjector: A Phase II Study
por: Kaminetsky, Jed, et al.
Publicado: (2015)

Accidental self-administration of an epinephrine autoinjector by a toddler
por: Edgerley, Sarah, et al.
Publicado: (2021)

Update on subcutaneous methotrexate for inflammatory arthritis and psoriasis
por: Vena, Gino Antonio, et al.
Publicado: (2018)

Nano Methotrexate versus Methotrexate in Targeting Rheumatoid Arthritis
por: Salem, Heba F., et al.
Publicado: (2022)

Results of a human factors experiment of the usability and patient acceptance of a new autoinjector in patients with rheumatoid arthritis
por: Schwarzenbach, Florence, et al.
Publicado: (2014)

Patient Perceptions and Preferences of Two Etanercept Autoinjectors for Rheumatoid Arthritis: Findings from a Patient Survey in Europe
por: Thakur, Kunal, et al.
Publicado: (2016)

Addition Of A Sleeve To The Etanercept Autoinjector (Enbrel(®) MyClic(®)) Improves Ease Of Use In Patients With Rheumatoid Arthritis
por: Rekaya, Naceur, et al.
Publicado: (2019)

Methotrexate alone and methotrexate combined with etanercept in treatment of rheumatoid arthritis
por: Rexhepi, Sylejman, et al.
Publicado: (2012)

Methotrexate Hepatotoxicity in Patients with Rheumatoid Arthritis
por: Sotoudehmanesh, R, et al.
Publicado: (2010)

Adherence to Methotrexate therapy in Rheumatoid Arthritis
por: Arshad, Nasim, et al.
Publicado: (2016)

Does persistence to methotrexate treatment in early rheumatoid arthritis have a familial component?
por: Sysojev, Anton Öberg, et al.
Publicado: (2022)

Methotrexate efficacy and tolerability after switching from oral to subcutaneous route of administration in juvenile idiopathic arthritis
por: Żuber, Zbigniew, et al.
Publicado: (2016)

Optimal dosage and route of administration of methotrexate in rheumatoid arthritis: a systematic review of the literature
por: Visser, K, et al.
Publicado: (2008)

Immune response in LPD during methotrexate administration (MTX-LPD) in rheumatoid arthritis patients
por: Saito, Shuntaro, et al.
Publicado: (2019)

Prevalence of methotrexate intolerance in rheumatoid arthritis and psoriatic arthritis
por: Bulatović Ćalasan, Maja, et al.
Publicado: (2013)

Benefits of Switch from Oral to Subcutaneous Route on Adherence to Methotrexate in Patients with Rheumatoid Arthritis in Real Life Setting
por: Senbel, Eric, et al.
Publicado: (2021)

Development of a Novel Methotrexate-Loaded Nanoemulsion for Rheumatoid Arthritis Treatment with Site-Specific Targeting Subcutaneous Delivery
por: Suresh, Parvathy, et al.
Publicado: (2022)

Real-world evidence on methotrexate-free subcutaneous tocilizumab therapy in patients with rheumatoid arthritis: 24-week data from the SIMPACT study
por: Nagy, György, et al.
Publicado: (2022)

Effectiveness and safety of intravenous golimumab with and without concomitant methotrexate in patients with rheumatoid arthritis in the prospective, noninterventional AWARE study
por: Broadwell, Aaron, et al.
Publicado: (2023)

Oral and Subcutaneous Administration of a Near-Infrared Fluorescent Molecular Imaging Agent Detects Inflammation in a Mouse Model of Rheumatoid Arthritis
por: Bhatnagar, Sumit, et al.
Publicado: (2019)

A Pharmacokinetic Bioequivalence Study of Fremanezumab Administered Subcutaneously Using an Autoinjector and a Prefilled Syringe
por: Cherniakov, Irina, et al.
Publicado: (2021)

Impact of tocilizumab administered intravenously or subcutaneously on patient-reported quality-of-life outcomes in patients with rheumatoid arthritis
por: Strand, Vibeke, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5vsoa7d3ngr9ut7157p8pgt5s3